62 Glomerulonephritis
Glomerulonephritis (GN) is a term used to describe an inflammatory insult to the kidney’s glomeruli. A clinical pattern of hematuria, proteinuria, hypertension, red blood cell (RBC) casts, azotemia, oligoanuria, and edema occurs in various combinations. The inciting process varies from infectious to immunologic and from autoimmune to hereditary. Prompt recognition of GN is important because this disease can result in hypertensive emergency, hyperkalemia, heart failure, pulmonary edema, and renal failure. In addition, early diagnosis of GN permits prompt medical treatment of destructive subtypes that can cause long-term renal damage. Supportive care consists of strict attention to fluid and electrolyte management and blood pressure control. Certain types of GN require specific medical management to combat renal inflammation. An understanding of the diagnosis and management of GN ensures the best chance at reducing immediate morbidity and mortality as well as reducing the likelihood of progression to chronic kidney disease (CKD).
Etiology and Pathogenesis
Most glomerulonephritides result from either circulating immune complex deposition within the glomerulus or in situ immune complex formation. This activates complement, as well as cellular and humoral pathways of inflammation. Within the glomerulus, there can be endothelial, epithelial, and mesangial hypercellularity, infiltration of leukocytes, thickening or duplication of the glomerular basement membrane, and necrosis (Figure 62-1). This results in loss of capillary integrity and obstruction of blood flow through the glomerular capillary loops. This capillary injury and obstruction of glomerular blood flow leads to the fluid overload, oligoanuric renal failure, hematuria, and RBC casts.
Differential Diagnosis
The two most common causes of GN in children are acute postinfectious GN (APIGN) and IgA nephropathy (IgAN). Other less common but important causes of GN include Henoch-Schönlein purpura (HSP), membranoproliferative GN (MPGN), rapidly progressive GN (RPGN), antineutrophilic cytoplasmic antibody– (ANCA-) positive vasculitis, systemic lupus erythematosus (SLE), and hemolytic-uremic syndrome (HUS).
Acute Postinfectious Glomerulonephritis
Acute poststreptococcal GN (APSGN) is the most common cause of APIGN in children and has a higher incidence in developing countries (Figure 62-2). APSGN is caused by nephritogenic forms of Lancefield group A streptococci. In most cases, there is clinical or laboratory evidence of antecedent streptococcal infection. APSGN must be confirmed or ruled out before looking for less common causes of post infectious GN (Staphylococcus aureus, Streptococcus viridans).
APSGN is characterized by sudden onset and variable presentation of hypertension, periorbital, lower extremity edema, oliguria, and painless gross hematuria. Urine microscopy reveals RBC casts. The glomerular damage in APSGN is immune mediated, with antigen–antibody reactions occurring in the circulation or in situ in glomeruli. These antigen–antibody reactions activate the alternative complement pathway cascade with reduction in the serum C3 concentration.
By light microscopy, findings in APSGN include glomerular enlargement, mesangial cell expansion and proliferation, and neutrophil exudation (see Figure 62-2). Electron microscopy (EM) reveals discrete subepithelial deposits.
IgA Nephropathy
IgA Nephropathy (IgAN) is an immune complex–mediated GN. Its course is highly variable and can range from asymptomatic microhematuria to recurrent episodes of gross hematuria to hypertension and acute and chronic renal failure. In Japan, of the children found by mass screening to have IgAN, 70% had asymptomatic microscopic hematuria. In these cases, IgAN is clinically silent. However, in up to 20% of patients who are referred to a pediatric nephrologist, IgAN will progress over decades to chronic renal failure.
The etiology of this disease is unknown. Although many children with IgAN present 1 to 2 days after the beginning of an upper respiratory infection, no infectious etiology has ever been identified. Most IgAN is sporadic, although an autosomal dominant form with incomplete penetrance has been found. Abnormally glycosylated IgA1 is found in the circulation and deposits in the skin and mesangium of the kidneys. The deposition of IgA in the mesangium causes activation of cytokines and growth factors, leading to mesangial expansion and extracellular matrix deposition.
Light microscopic findings show cellular and matrix expansion of the mesangium with deposition of IgA by immunofluorescence. Electron microscopy reveals electron dense deposits within the mesangium that may extend along capillary loops.
Henoch-Schönlein Purpura Nephritis
HSP nephritis is a small vessel vasculitis caused by IgA deposition within the glomeruli in the context of systemic HSP. Renal manifestations may present weeks after the onset of systemic HSP; rarely is it the first feature manifested in this syndrome. Prevalence of renal manifestations is subject to observer bias. Pediatric nephrology centers report that 50% of children with HSPN have hematuria and proteinuria, 8% have acute GN (AGN), 13% have nephrotic syndrome, and 29% have a mixed nephritic and nephrotic syndrome. Treatment of HSP nephritis is controversial because of a high rate of spontaneous remission and the lack of rigorous studies regarding treatment. Prognostic features are noted in Table 62-1.
Table 62-1 Poor Prognostic Features of Selected Glomerulonephritides and Recommended Treatment
Disease | Poor Prognostic Features | First-Line Treatment |
---|---|---|
IgAN | Proteinuria >1 g/24 h, hypertension, azotemia, interstitial fibrosis, sclerotic glomeruli | If medical treatment,- corticosteroid ACEI |
HSP | Presence of nephritic or nephrotic syndrome, renal failure, nephrotic-range ongoing proteinuria, interstitial fibrosis, sclerotic glomeruli | If medical treatment needed, corticosteroids, immunosuppressive agents |
SLE | Diffuse proliferative GN (WHO Class IV), ↑ creatinine, persistent HTN, chronic anemia, nephrotic-range proteinuria | Corticosteroid therapy, cyclophosphamide, azathioprine, MMF |
ANCA+ vasculitis or pauci-immune GN | Crescents on biopsy, frequent relapses | Corticosteroid therapy, azathioprine, MMF, cyclophosphamide |
MPGN | Type II disease, nephrotic-range proteinuria | Corticosteroid therapy |
ANCA, antineutrophilic cytoplasmic antibody; AZA, azathioprine; CCS, corticosteroids; GN, glomerulonephritis; HSP, Henoch-Schönlein purpura; HTN, hypertension; IgAN, IgA nephropathy; MMF, mycophenolate mofetil; MPGN, membranoproliferative glomerulonephritis; SLE, systemic lupus erythematosus; WHO, World Health Organization.

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

